Collins was tipped to the drug trial's failure because he served on the board of the company, a position that ethics experts called unusual and potentially problematic for a lawmaker.
By Tory Newmyer The Washington Post, The Providence Journal
Fri, 08/10/2018 - 12:03am
Collins was tipped to the drug trial's failure because he served on the board of the company, a position that ethics experts called unusual and potentially problematic for a lawmaker.